Mortality and Causes of Death in Patients With Polycythemia Vera
December 6th 2020Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on what polycythemia vera (PV) is and why it was important to understand mortality and causes of death among patients with PV.
The Causes of Sickle Cell Disease and Beta-thalassemias
December 5th 2020Pharmacy Times® interviewed Christopher Moxham of Fulcrum Therapeutics, on what sickle cell disease and beta-thalassemias are caused by, and how hemoglobin gamma can prevent or reduce disease-related pathophysiology in these disorders.
The Overall Importance of Preparing the Public for a General COVID-19 Vaccine
December 2nd 2020Pharmacy Times spoke with Angela Kashuba, Dean of UNC Eshelman School of Pharmacy and Patrick Brown, UNC Eshelman School of Pharmacy Alumni, about the importance of preparing pharmacists and students to vaccinate the general public with the COVID-19 vaccine.
Dosing Patients with Kidney Disease Presents Unique Challenges
December 1st 2020In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.
Strategies for Encouraging Collaboration in Clinical Decision Making
November 24th 2020In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.
Pediatricians Express Concerns About HHS Authorization of Pharmacists to Deliver Childhood Vaccines
November 19th 2020In a discussion with Pharmacy Times, Susan DiGregorio, BS Pharm, MS, RPh, director of clinical pharmacy development at Community Care Rx, said that collaborating with pediatricians and other health care providers is essential for pharmacists to effectively administer vaccines to children.
More Than 500 Therapeutics Being Investigated for COVID-19
November 19th 2020Pharmacy Times spoke with Michael Haydock, senior director of content for cardiovascular, metabolic, and infectious diseases at Informa Pharma Intelligence, about investigational therapeutics for COVID-19 and what’s in the pipeline.
The Work of the COVID-19 and Cancer Consortium During the COVID-19 Pandemic
November 10th 2020Pharmacy Times® interviewed Petros Grivas, MD, PhD, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the work of the COVID-19 and Cancer Consortium.
How Using Social Determinants of Health in Tandem With Clinical Data Can Benefit Pharmacies
November 6th 2020Pharmacy Times® interviewed Rich Morino, senior director of health care solutions at LexisNexis, on how using social determinants of health in tandem with clinical data can benefit pharmacies.